VRAI peer analysis
VRAI (VRAI) against its competitors: price, today's move, 1-year return and market value side by side.
- VRAI's peers: DTRE (Disruptive Real Estate), FTXH (Pharmaceuticals), JCHI (JPMorgan China), LST (Leuthold Industries), PEMX (Putnam Emerging Markets Ex-China ETF), QLVE (Emerging Markets Quality), RBLD (First Trust Alerian U.S. NextGen Infrastructure ETF), RNEM (Emerging Markets Equity).
VRAI and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| DTRE Disruptive Real Estate | $40.40 | -1.85% | 1.95% | – |
| FTXH Pharmaceuticals | $42.34 | 0.65% | 33.95% | $1.15B |
| JCHI JPMorgan China | $46.44 | -1.76% | -17.19% | – |
| LST Leuthold Industries | $44.27 | -1.96% | 13.49% | – |
| PEMX Putnam Emerging Markets Ex-China ETF | $71.38 | -1.97% | 8.89% | – |
| QLVE Emerging Markets Quality | $30.41 | -1.30% | 3.35% | – |
| RBLD First Trust Alerian U.S. NextGen Infrastructure ETF | $81.19 | -1.57% | 9.35% | – |
| RNEM Emerging Markets Equity | $55.33 | -0.22% | -0.07% | $16.60M |
| SCAP Small Cap Income | $32.80 | -2.31% | -5.24% | – |
| SHRY Shareholder Yield | $46.78 | -1.45% | 15.63% | – |
| VRAI Virtus Real Asset Income ETF | $27.35 | -1.30% | 15.20% | – |